9Naghavi M,Libby P,Falk E,et al.From vulnerable plaque to vulnerable patient:a call for new definitions and risk assessment strategies:part Ⅰ[J]. Circulation,2003;108 (14):1664-72.
10Zeng B,Prasan A,Fung KC,et al.Elevated circulating levels of matrix metalloproteinase-9 and-2 in patients with symptomatic coronary artery disease[J].Intern Med J,2005;35(6):331-5.
